Ebv-related Hemophagocytic Lymphohistiocytosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-23
Clinical Trial Update: Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis [NA]
A clinical trial at Beijing Children's Hospital is evaluating letermovir prophylaxis in pediatric patients with EBV-associated T/NK-cell Lym…